Itamar Medical Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was USD 12.560 million compared to USD 8.885 million a year ago. Operating loss was USD 4.567 million compared to USD 3.218 million a year ago. Net loss was USD 4.746 million compared to USD 3.242 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, sales was USD 24.537 million compared to USD 17.263 million a year ago. Operating loss was USD 9.863 million compared to USD 5.175 million a year ago. Net loss was USD 10.269 million compared to USD 5.240 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.